LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Energy?src=hash" target="_blank"gt;#Energylt;/agt;–Technavio predicts the global neurodegenerative diseases therapeutics market to grow at a CAGR of nearly 8% by 2022.

Source link